Serum coding and non‐coding RNAs as biomarkers of NAFLD and fibrosis severity

BACKGROUND & AIMS: In patients with non‐alcoholic fatty liver disease (NAFLD), liver biopsy is the gold standard to detect non‐alcoholic steatohepatitis (NASH) and stage liver fibrosis. We aimed to identify differentially expressed mRNAs and non‐coding RNAs in serum samples of biopsy‐diagnosed m...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Mauro, Stefania, Scamporrino, Alessandra, Petta, Salvatore, Urbano, Francesca, Filippello, Agnese, Ragusa, Marco, Di Martino, Maria T., Scionti, Francesca, Grimaudo, Stefania, Pipitone, Rosaria M., Privitera, Graziella, Di Pino, Antonino, Scicali, Roberto, Valenti, Luca, Dongiovanni, Paola, Fracanzani, Anna, Rabuazzo, Agata M., Craxì, Antonio, Purrello, Michele, Purrello, Francesco, Piro, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Metabolic Liver Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771597/
https://www.ncbi.nlm.nih.gov/pubmed/31169972
http://dx.doi.org/10.1111/liv.14167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771597/
https://www.ncbi.nlm.nih.gov/pubmed/31169972
http://dx.doi.org/10.1111/liv.14167

Ejemplares similares